Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Global Personalized Medicine Biomarkers Market Size study & Forecast, by Indication (Oncology, Diabetes, Autoimmune Diseases, Cardiology, Others) by Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring) and Regional Analysis, 2022-2029
... valued at approximately USD 11.76 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 15.51% over the forecast period 2022-2029. Personalized medicine biomarkers are essential tools that are ... Read More
-
Diabetes Care Devices Global Market Briefing 2023
... per capita consumption, the market was $7.5 and in terms of global GDP, the market was 0.05%. Diabetes care devices was the third largest segment within the medical equipment market accounting for 9.1% preceded and ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
Diabetes Assays Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
... (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Diabetes Assays market for the year 2020 and beyond. ... Read More
-
Global Diabetes Care Devices Market 2023-2029
... a hormone that regulates blood glucose. Hyperglycaemia, also called raised blood glucose or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's ... Read More
-
United Kingdom (United Kingdom) Diabetes Care Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... CAGR of more than 5% during 2022- 2027. The COVID-19 pandemic had a substantial impact on United Kingdom’s diabetes care devices. According to The British Diabetic Association, “The pandemic has had and continues to have, ... Read More
-
Saudi Arabia Diabetes Care Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... period (2022-2027). In Riyadh, hospitalized COVID-19 patients had a significant frequency of diabetes mellitus. Even though people with diabetes have a higher mortality rate than people without the disease, other factors, including advanced age, congestive ... Read More
-
Europe Insulin Infusion Pumps Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... The COVID-19 pandemic has had a significant impact on the market studied. Type-1 diabetes patients have been more affected during the pandemic since people with diabetes have weak immune systems. People with diabetes are also ... Read More
-
Diabetes Care Drugs Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... a chronic, life-threatening disease with no known cure. As per the World Health Organization, there are over 400 million people with diabetes across the world, and its treatment constitutes around 12% of the total healthcare ... Read More
-
Global Diabetic Dietary Supplements Market Growth 2023-2029
... comprehensive analysis by region and market sector of projected Diabetic Dietary Supplements sales for 2023 through 2029. With Diabetic Dietary Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed ... Read More
-
Injection Pen Market Forecast to 2028 - Global Analysis by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Other Therapies), and End User (Hospitals and Clinics, Home Care, and Others)
... Clinics, Home Care, and Others) The injection pen market is expected to reach US$ 60,332.97 million by 2028 from US$ 37,261.35 million in 2021; it is estimated to register a CAGR of 7.14% from 2022 ... Read More
-
Global Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 GLP-1 receptor agonists are a type of non-insulin medication used to treat type 2 diabetes in conjunction with diet and exercise. These medications are used to help lower blood glucose ... Read More
-
Global Biosimilar Insulin Market Growth 2023-2029
... designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's ... Read More
-
Diabetic Foot Ulcer - Drug Pipeline Landscape, 2023
... is one of the health complications caused due to uncontrolled diabetes, people with diabetes may also suffer from lower extremity arterial disease, which is a condition that leads to reduced blood flow. These problems make ... Read More
-
Diabetic Gastroparesis - Drug Pipeline Landscape, 2023
... a digestive disorder with a high incidence among people with long-standing diabetes. Gastroparesis can cause due to the damage of vagus nerve. Certain medications, such as opioid pain relievers, some antidepressants, and high blood pressure ... Read More
-
Global Diabetic Neurotherapy Foot Ulcers Market - 2023-2030
... at a CAGR of 8.4% during the forecast period (2023-2030). The most frequent foot wounds resulting in lower extremity amputation are diabetic ulcers. General practitioners are crucial in the early detection or prevention of diabetic ... Read More
-
2023 Global: Artificial Pancreas Device System (Adps) - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Global Insulin Resistance Market - 2023-2030
... CAGR of 4.2% during the forecast period (2023-2030). Insulin resistance is an abnormally slow physiologic reaction to normal insulin concentrations. When cells in the muscles, fat, and liver do not respond to insulin well and ... Read More
-
Diabetic Retinopathy - Drug Pipeline Landscape, 2023
... blood causes blockage of the retina's small blood capillaries, impeding blood flow resulting in cloudy or blurred vision. There are two types of diabetic retinopathy non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. A high sugar ... Read More
-
Diabetic Neuropathy - Drug Pipeline Landscape, 2023
... damage is called neuropathy. Diabetic neuropathy can affect different parts of the body, including the feet, legs, hands, and arms. It can also affect the digestive system, urinary system, blood vessels, and heart. Diabetic neuropathy ... Read More
-
In Vitro Diagnostics Market by Product and Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Infectious Disease), End User (Hospitals, Clinics) - Forecast to 2027
... to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%. The growing adoption of point-of-care devices and rapid tests for early disease diagnosis, and the rising government ... Read More
-
Diabetic Nephropathy - Drug Pipeline Landscape, 2023
... of kidney to remove wastes and extra fluid from the body. The most common cause of Diabetic Nephropathy is Type 1 and Type 2 Diabetes which increase the blood pressure. Any damage caused to blood ... Read More
-
Global Compression Socks Market Growth 2023-2029
... ankle and up the leg and help relieve symptoms and slow the progress of varicose veins. They are designed to gently squeeze the legs, which promotes good blood flow in the veins. Patients with venous ... Read More
-
Diabetes Nutrition Market, by Form (Fixed Dental Prosthetic (Tablets, Capsules, Powders, Soft Gels, Liquids), by Product Type (Proteins & Amino Acids, Omega-3 Fatty Acids, Alpha-Lipoic Acid (ALA), Herbal Supplements, Soluble Fiber, Probiotics, Carbohydrates, Others (Antioxidants, etc.)), by Age Group (Paediatric, Adults), by Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), by Sales Channel (Hospitals, Retail Pharmacies, Online Pharmacies and Others (Wholesaler, Convenience Stores, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... etc.)), by Age Group (Paediatric, Adults), by Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), by Sales Channel (Hospitals, Retail Pharmacies, Online Pharmacies and Others (Wholesaler, Convenience Stores, etc.), and by Region (North ... Read More
-
Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... with no available cure. According to IDF Europe, there are more than 60 million diabetic people in the European Region; by 2045, this number will rise by 13%. In the Netherlands, the prevalence of diabetes ... Read More
Research Assistance
